Sonnet Biotherapeutics Holdings Inc (NASDAQ:SONN)

BATS BZX Real-Time Price
As of 9:42am ET
 +0.0187 / +5.37%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Sonnet Biotherapeutics Holdings Inc have a median target of 6.70, with a high estimate of 6.70 and a low estimate of 6.70. The median estimate represents a +1,725.61% increase from the last price of 0.37.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Sonnet Biotherapeutics Holdings Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 30.00%
Growthannually 71.64%


Growthquarterly -100.00%
Growthannually 0.00%
Key to the earnings and sales forecast charts.